OncoSec Medical Gets Double Exposed (ONCS)

OncoSec Medical (OTC: ONCS) announced that it would be presenting at the 3rd Annual Cancer Immunotherapy Conference on October 4, 2012, at the New York Academy of Medicine. The conference meshes researchers, clinicians, investors and business leaders into a single day event for the purpose of exchanging information and opportunities. President and CEO Punit Dhillon will present […]

OncoSec Medical Gains on Optimistic Cancer Immunotherapy Update (ONCS)

OncoSec Medical’s (OTC: ONCS) CEO and President, Punit Dhillon, revealed in an interview published in Seeking Alpha that not only will the company provide the subset data from the melanoma and Merkel cell program before the end of 2012, but will also provide an update on deals pertaining to the NeoPulse program. The CEO also expressed […]

Can International Certification Help Cure OncoSec Medical’s Doldrums? (ONCS)

OncoSec Medical (OTC: ONCS) announced today it had received certification to the International Organization for Standardization. The certification means the company’s manufacturing processes are compliant with the European Union. Traders initially greeted the news with a degree of indifference as the stock opened unchanged at $0.20. The first full hour of trading garnered more enthusiasm […]

Talon Therapeutics Adds Its Name to the Hit Parade (TLON)

It certainly appears that biomedical is the theme for the week in over-the-counter stocks. Today, the stock of Talon Therapeutics (OTC:TLON) popped on to the radar screen after posting a 10% gain for the session on 1.4 million shares.  Earlier in the week, InVivo Therapeutics (OTC: NVIV) and Oncosec Medical (OTC: ONCS) surged on volume […]

InVivo Therapeutics Holdings Climbs, Gaining Popularity with the Public (NVIV)

After a month long fall, InVivo Therapeutics (OTC: NVIV) finally turned the corner, rising an impressive 12.8% to $2.38. What is even more impressive about this sudden turnaround is that the company did it amidst a complete market drop. Other penny stock success stories such as Great Wall Builders (OTC: GWGB) and OncoSec Medical (OTC: […]